154 related articles for article (PubMed ID: 33763357)
1. Systematic Profiling of Alternative Splicing Events in Ovarian Cancer.
Liu J; Lv D; Wang X; Wang R; Li X
Front Oncol; 2021; 11():622805. PubMed ID: 33763357
[TBL] [Abstract][Full Text] [Related]
2. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
Zhu J; Chen Z; Yong L
Gynecol Oncol; 2018 Feb; 148(2):368-374. PubMed ID: 29191436
[TBL] [Abstract][Full Text] [Related]
3. Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.
Liu Q; Zhang H; Yang X; Liu X; Yin F; Guo P; Yin Y; Zheng K; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):126. PubMed ID: 35282039
[TBL] [Abstract][Full Text] [Related]
4. Alternative Splicing: A New Therapeutic Target for Ovarian Cancer.
Yao S; Yuan C; Shi Y; Qi Y; Sridha R; Dai M; Cai H
Technol Cancer Res Treat; 2022; 21():15330338211067911. PubMed ID: 35343831
[No Abstract] [Full Text] [Related]
5. Alternative splicing acts as an independent prognosticator in ovarian carcinoma.
Ouyang Y; Xia K; Yang X; Zhang S; Wang L; Ren S; Zhou H; Liu Y; Tang F
Sci Rep; 2021 May; 11(1):10413. PubMed ID: 34001978
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance-associated alternative splicing signatures in serous ovarian cancer.
Sun T; Yang Q
Oncol Lett; 2020 Jul; 20(1):420-430. PubMed ID: 32565967
[TBL] [Abstract][Full Text] [Related]
7. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Front Oncol; 2020; 10():1257. PubMed ID: 32793502
[No Abstract] [Full Text] [Related]
8. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Yang L; He Y; Zhang Z; Wang W
PeerJ; 2019; 7():e8245. PubMed ID: 31844595
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer.
Liu M; Khushbu RA; Chen P; Hu HY; Tang N; Ou-Yang DJ; Wei B; Zhao YX; Huang P; Chang S
Front Oncol; 2021; 11():705929. PubMed ID: 34722250
[TBL] [Abstract][Full Text] [Related]
10. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
Liu Y; Jia W; Li J; Zhu H; Yu J
Front Oncol; 2020; 10():587343. PubMed ID: 33117720
[No Abstract] [Full Text] [Related]
11. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
Zhang D; Zou D; Deng Y; Yang L
J Ovarian Res; 2021 Sep; 14(1):120. PubMed ID: 34526089
[TBL] [Abstract][Full Text] [Related]
12. Development of alternative splicing signature in lung squamous cell carcinoma.
Yan JQ; Liu M; Ma YL; Le KD; Dong B; Li GH
Med Oncol; 2021 Mar; 38(5):49. PubMed ID: 33772655
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive characterization of the alternative splicing landscape in ovarian cancer reveals novel events associated with tumor-immune microenvironment.
Sun D; Zhao X; Yu Y; Li W; Gu P; Zhi Z; Xu D
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35137909
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.
Song J; Liu J; Lv D; Meng X; Li X
Front Genet; 2021; 12():767259. PubMed ID: 34737768
[TBL] [Abstract][Full Text] [Related]
16. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
18. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
19. Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer.
Wang L; Bi J; Li X; Wei M; He M; Zhao L
J Cancer; 2020; 11(22):6530-6544. PubMed ID: 33046974
[No Abstract] [Full Text] [Related]
20. Comprehensive analysis of prognosis-related alternative splicing events in ovarian cancer.
Wang S; Wang S; Zhang X; Meng D; Xia Q; Xie S; Shen S; Yu B; Hu J; Liu H; Yan W
RNA Biol; 2022 Jan; 19(1):1007-1018. PubMed ID: 35980273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]